Drug intelligence / Profile preview

Nano-arthrocen

Development stage
Preclinical
Lead developer
Pharmin USA
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nanoparticles → Drug Delivery Systems, Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Nano-arthrocen (also known as ROCEN or NANOCEN) is a topical nanoliposomal formulation of avocado/soybean unsaponifiables (ASU) developed by Pharmin USA. ASU is a natural extract composed of phytosterols, tocopherols, and other bioactive lipids in a 1:2 ratio of avocado to soybean oil. By encapsulating ASU in liposome-based nanocarriers (LBNs), Nano-arthrocen achieves enhanced skin penetration, sustained release, and localized tissue accumulation. It exerts anti-inflammatory, analgesic, and tissue-regenerative effects by downregulating pro-inflammatory cytokines (such as TNF-alpha, IL-1beta, IL-6, IL-8, IL-17, and IL-23), inhibiting NF-kappaB translocation, and suppressing COX-2 and iNOS expression, while simultaneously stimulating the production of anabolic factors like transforming growth factor-beta (TGF-beta) and collagen. Nano-arthrocen is being developed under the brand names Nanocen (a 2% gel/cream for musculoskeletal pain and joint conditions like osteoarthritis) and Rocen (a 2% gel/cream for skin remodeling in cutaneous wounds, burns, atopic dermatitis, and psoriasis).

Brand names
NanocenRocen
Other names
Nano-ArthrocenNanolipo-ASUnanoliposomal Arthrocennanoliposomal avocado/soybean unsaponifiables
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))TGFB1 (Transforming growth factor Beta-1 proprotein)PGE2 (Prostaglandin E2)IL1B (Interleukin-1 beta)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Nano-arthrocen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nano-arthrocen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call